# Lumigenex (Suzhou) co

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lumigenex-suzhou-co

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.lumigenex.com
- Latest round: Series B (Jul 8, 2019)
- Investors on record: 5

## About

Founded in 2010 and based in Suzhou, China, Lumigenex (Suzhou) co LTD. operates as a medical equipment manufacturing company that focuses on the production and sales of in vitro diagnosis and infection control products. It was recognized as the National High-tech Enterprise. The company cooperated with Kimberly-Clark Corporation, Beijing Anzhen Hospital, Affiliated to Capital Medical University, and other enterprises and institutions. Aimin He, the company's founder, graduated from MIT and is also a professor at Soochow University. In July 2019, Lumigenex (Suzhou) co LTD. closed a series B funding. In 2021, the company's new coronavirus antigen test kit obtained FDA certification in multiple countries.

The company's main business is the research, development, production, and sales of in vitro diagnostic products and infection control products. Its products include quantitative POCT products, biochemical reagents, nano-microspheres, biofilms, and other fields for cardiovascular diseases, women's health, infection control, tumor screening, drug abuse, and food safety.

The company generates revenue by selling vitro diagnosis and infection control products.

## Funding rounds

- Series B, Jul 8, 2019 — CR Capital, Jolmo Capital, Sangel Capital
- Series A, Jan 14, 2016 — Legend Star, Suzhou TechWisdom Capital

## Investors

- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A
- Suzhou TechWisdom Capital — Series A
- CR Capital (https://capitalatlas.ai/funds/cr-capital) — Series B
- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Series B
- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Series B